Posts for the 'Digitek' Category
Digoxin Lawsuit Consolidation in West Virginia
Last week the United States Judicial Panel on Multidistrict Litigation ordered that any individual Digoxin lawsuit filed as a result of the April 2008 Digitek recall should be transferred to the Southern District of West Virginia. All cases will be consolidated for pretrial litigation and discovery before Judge Joseph R. Goodwin.
Following Digitek recall, Actavis issues recall for 65 other drugs made at same plant
On Monday, Actavis Totowa, LLC, the maker of Digitek, recalled over 65 different generic drugs made at their New Jersey manufacturing plant. Following an FDA inspection earlier this year, a number of violations of good manufacturing practices were identified. In April 2008, Actavis issued a Digitek recall for all lots of their generic digoxin which were made at the same plant, after they discovered that tablets had been commercially sold which were twice as thick as they were supposed to be.
>>PRIOR POST (5/4/2008): Digitek Recall Due to Risk of Digoxin Overdose
Digitek Overdose Lawsuits: Double strength tablets increased risk of digitalis toxicity
The lawyers at Saiontz, Kirk & Miles, P.A. are investigating potential Digitek overdose lawsuits for individuals who experienced digitalis toxicity resulting in severe injuries or the need for medical treatment. Manufacturing defects allowed certain Digitek (digoxin) tablets to be sold with twice the appropriate amount of ingredient, increasing the risk of a digoxin overdose.
Digitek lawsuits have been filed and more cases are coming
Less than two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being investigated throughout the country by individuals who are trying to determine if they may be entitled to compensation through a Digitek lawsuit.
Ethex Morphine Recall due to risk of Morphine Overdose
A nationwide Ethex morphine recall was issued yesterdat for 60 mg extended release morphine sulfate tablets. It was discovered that certain pills sold may contain up to double the appropriate medication and be twice as thick as normal. The recall lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Ethex morphine lawsuits for individuals who suffered a morphine overdose or death while taking the medication.
>>FDA LINK: Ethex Morphine Sulfate Recall
Extent of Digitek Problems remains unclear
It has been over three weeks since a nationwide Digitek recall was issued after it was discovered that some tablets could contain twice the appropriate strength. However, very little information has been released about the extent of the Digitek problems and exactly how long double strength tablets have been sold.
Digitek Class Action Lawsuits filed
Two weeks after a nationwide Digitek recall, several class action lawsuits have already been filed on behalf of users who took the heart drug. Manufacturing problems resulted in some tablets being sold with twice as much of the active medication as they were supposed to have. While Digitek class action suits are seeking reimbursement for the cost of the prescription medication and funding for medical monitoring, those who have suffered severe injuries or death after taking Digitek, should consider pursuing an individual lawsuit.
Digitek recall letters being sent by pharmacies
Following last weeks Digitek recall, people are receiving phone calls and pharmacy letters notifying them that their heart drug may be unsafe. All lots of the Digitek, a generic form of digoxin, were removed from shelves after it was discovered that some tablets could contain twice the appropriate amount of the active drug. This could increase the risk of digitalis toxicity, a serious and potentially fatal illness. In an unusual move, pharmacists are being required to attempt to notify all customers who filled a prescription.
>>FDA LINK: Generic Digoxin Recall
Digitek Recall due to risk of Digitalis Toxicity
Last week Actavis Totowa announced a nationwide Digitek recall due to manufacturing defects which caused some of the digoxin tablets to contain double the appropriate amount of active ingredients. This could lead to a substantial risk of a serious and potentially fatal illness, known as digitalis toxicity, especially among those with renal failure. The lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Digitek recall lawsuits throughout the United States.
